Europe

The EU over the last 7 years has cravenly ducked the industrial fight against China, attempting to expand its exports while America shoulders the costs. That cannot be allowed to continue as the new Trump administration ratchets up pressure against our common adversary.

The incoming administration is unlikely to take kindly to Europe's continuing antitrust attacks against Apple and other U.S. technology companies using a highly aggressive approach to DMA enforcement.

While it remains uncertain what Ribera’s tenure will bring, early signs indicate she could drag sustainability into competition policy and pursue an unacceptable double standard of pushing European firms to grow while singling out American ones for aggressive enforcement.

Unfortunately, new proposed guidelines for enforcing against abusive exclusionary conduct untether liability from likely harms to competition and consumer welfare.

Watch now for a lively and insightful webinar featuring leading experts from Europe.

Europe needs to pump the brakes on new regulations before it can properly assess the long-term effects of the GDPR, DSA, DMA, and AI Act.

Mario Draghi's 2024 report addresses the EU's biopharmaceutical decline, citing challenges like underfunded research, fragmented pricing, and competition from the U.S. and China. It recommends reforms but underplays the impact of EU drug price controls on innovation.

The Draghi Report is a monumental but imperfect step in the right direction to correct Europe’s failing competition policy and better drive European innovation and productivity growth.

While increasing children’s online safety and privacy are important goals, it is important not to infringe on others’ rights, or children’s own rights, in the process.

The EU should adopt a more flexible, innovation-driven approach to AI regulation to boost global competitiveness, according to the European Competitiveness Report by Mario Draghi.